Antibiotic resistance is the ability of bacteria to survive and grow despite exposure to drugs designed to kill them. In 2019, resistant bacteria directly caused an estimated 1.27 million deaths worldwide and played a role in nearly 5 million more. It is now one of the most urgent threats to global public health.
How Bacteria Become Resistant
Bacteria develop resistance through random genetic mutations that happen naturally as they reproduce. When an antibiotic kills most of a bacterial population but a few survive because of a lucky mutation, those survivors multiply and pass the mutation on to their offspring. Over time, the entire population can become resistant. This process is accelerated every time antibiotics are used, whether appropriately or not, because each exposure creates another round of selective pressure favoring resistant bacteria.
At the cellular level, bacteria use four main strategies to defeat antibiotics. They can limit how much of the drug gets inside the cell by changing the structure of their outer membrane. They can modify the drug’s target inside the cell so the antibiotic no longer binds to it. They can produce enzymes that break down the drug or chemically alter it so it stops working. And they can actively pump the drug back out of the cell before it does any damage, using built-in molecular pumps originally designed to expel toxins.
A single bacterium might use one or several of these strategies at once, making some infections extremely difficult to treat.
How Resistance Spreads Between Bacteria
What makes antibiotic resistance especially dangerous is that bacteria don’t have to develop it on their own. They can share resistance genes with each other, even across completely different species, through a process called horizontal gene transfer. This happens in three main ways.
The most important is conjugation: one bacterium physically connects to another through a tiny tube-like structure and passes a copy of its resistance genes directly. This can happen between bacteria of the same species or between entirely different types of bacteria, which means a harmless gut bacterium carrying resistance genes can hand them off to a dangerous pathogen.
Bacteria can also pick up resistance genes from their environment. When resistant bacteria die and break apart, their DNA fragments linger. Other bacteria can absorb these fragments and incorporate the resistance genes into their own genome, a process called transformation. A third route involves viruses that infect bacteria (called bacteriophages), which can accidentally package resistance genes from one bacterium and deliver them to the next one they infect.
These sharing mechanisms mean that resistance can spread far faster than it would through mutation alone. A single resistance gene that appears in one species can jump to dozens of others in a relatively short time.
What Drives Resistance
The primary driver is antibiotic use itself. Every course of antibiotics, whether in a hospital, a doctor’s office, or a farm, creates conditions that favor resistant bacteria. Overuse and misuse accelerate the problem. Taking antibiotics for viral infections like colds or the flu, not finishing a prescribed course, or using leftover antibiotics without medical guidance all contribute.
Agriculture plays a significant role as well. Antibiotics are widely used in livestock, sometimes to treat sick animals but also to promote growth or prevent infections in crowded conditions. In the European Union, recent data shows antibiotic use in food-producing animals has actually dropped below human use in most countries, but globally the picture is less encouraging. Resistant bacteria from farms can reach people through food, water, and direct contact with animals.
Poor sanitation and inadequate infection control in healthcare settings also accelerate the spread. In hospitals, resistant organisms can pass from patient to patient on unwashed hands, contaminated surfaces, or shared equipment. In communities without clean water or proper sewage treatment, resistant bacteria circulate even more freely.
Why It Matters for Everyday Medicine
Antibiotic resistance doesn’t just threaten people with rare infections. It undermines routine medical care that most people take for granted. Surgical procedures depend on effective antibiotics to prevent post-operative infections. When resistance rises, those procedures become significantly riskier.
The numbers are already alarming. Globally, about 5.6% of cesarean sections result in surgical site infections, with rates reaching nearly 12% in parts of Africa. In gastrointestinal surgery, roughly one in five post-operative infections involves a bacterium resistant to the preventive antibiotics given before the procedure. In low-income countries, that figure rises to 36%. Patients colonized with certain resistant bacteria face more than double the normal infection rates after gastrointestinal surgery.
Cancer chemotherapy, organ transplants, joint replacements, and even routine dental work all rely on antibiotics to keep patients safe. As resistance grows, the risk-benefit calculation for all of these procedures shifts.
The Most Dangerous Resistant Bacteria
The World Health Organization maintains a priority list of the most threatening resistant bacteria, updated in 2024. It now covers 24 pathogens across 15 bacterial families, categorized into critical, high, and medium priority. At the top of the list are certain types of bacteria resistant to last-resort antibiotics, the drugs used when nothing else works. Drug-resistant tuberculosis is also a critical concern, as are resistant strains of Salmonella, gonorrhea, Pseudomonas (a common cause of hospital-acquired infections), and MRSA (methicillin-resistant Staphylococcus aureus).
Many of the most dangerous resistant bacteria are what scientists call gram-negative, meaning they have a double-layered outer membrane that makes them naturally harder for drugs to penetrate. This structural advantage, combined with acquired resistance mechanisms, makes some gram-negative infections nearly untreatable with existing antibiotics.
The Shrinking Arsenal of New Drugs
One of the most concerning aspects of antibiotic resistance is how few new drugs are being developed to replace the ones that no longer work. The number of antibiotics in the clinical development pipeline actually fell from 97 in 2023 to 90 in 2025. Since mid-2017, only 17 new antibiotics targeting priority pathogens have reached the market, and just two of those represent genuinely new classes of drugs. The rest are variations on existing types, meaning bacteria that have already developed resistance to those classes may quickly adapt.
Developing new antibiotics is expensive and slow, and pharmaceutical companies have limited financial incentive to invest. Unlike drugs for chronic conditions that patients take for years, antibiotics are used for short courses, and the most valuable new ones would be reserved as last-resort treatments, limiting sales further. This economic mismatch has left the pipeline dangerously thin at a time when new drugs are needed most.
The Economic Toll
Beyond the direct health consequences, antibiotic resistance is projected to drain more than $1 trillion annually from the global economy beyond 2030, according to estimates published in The Lancet. Those costs ripple across healthcare, agriculture, and food production. Resistant infections mean longer hospital stays, more expensive treatments, more time away from work, and higher mortality among working-age adults. In agriculture, the loss of effective antibiotics threatens livestock health and food safety, adding further economic strain.
What You Can Do
Individual actions genuinely matter in slowing resistance. Use antibiotics only when prescribed for a bacterial infection, and take the full course as directed, even if you feel better partway through. Never share antibiotics or use leftover medication from a previous illness. Basic hygiene, particularly regular handwashing and safe food handling, reduces infections in the first place, which means fewer antibiotics needed overall.
Staying current on vaccinations also helps. Vaccines prevent bacterial infections like pneumonia and whooping cough, reducing the need for antibiotics and limiting opportunities for resistance to develop. Choosing meat raised without routine antibiotic use, where that option is available, sends a market signal that matters at scale.